Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
14.42Price to Sales
VS
Market
Sector
Industry
History
$ 7.92Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information
Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYRA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYRA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 11.1M | 14.42 | $ 770K |
| 3/31/2025 | $ 6.76M | 5.7 | $ 1.19M |
| 12/31/2024 | $ 11.53M | 7.52 | $ 1.53M |
| 9/30/2024 | $ 18M | 12.24 | $ 1.47M |
| 6/30/2024 | $ 18.76M | 10.31 | $ 1.82M |
| 3/31/2024 | $ 314.58M | 187.25 | $ 1.68M |
| 12/31/2023 | $ 372.8M | 239.28 | $ 1.56M |
| 9/30/2023 | $ 154.01M | 108.23 | $ 1.42M |
| 6/30/2023 | $ 159.54M | 128.87 | $ 1.24M |
| 3/31/2023 | $ 85M | 65.14 | $ 1.3M |
Key Performance Insights, Last 5 Years
- LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, LYRA THERAPEUTICS INC's average P/S has been 466.75.
- The median P/S for LYRA THERAPEUTICS INC during this period was 56.27
- LYRA THERAPEUTICS INC reached its highest P/S over the past 5 years at 6.31K.
- The lowest P/S recorded by LYRA THERAPEUTICS INC in the same timeframe 5.7
LYRA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for LYRA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 140.52M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] LYRA - Price to Sales, Last 5 years
5.7
Minimum
Mar 31, 2025
6.31K
Maximum
Sep 30, 2021
466.75
Average
56.27
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |